Caesar J. Belbel

2013

In 2013, Caesar J. Belbel earned a total compensation of $912.4K as Executive Vice President, Chief Legal Officer and Secretary at ZIOPHARM Oncology, a 12% decrease compared to previous year.

Compensation breakdown

Bonus$61,250
Option Awards$500,340
Salary$350,000
Other$828
Total$912,418

Belbel received $500.3K in option awards, accounting for 55% of the total pay in 2013.

Belbel also received $61.3K in bonus, $350K in salary and $828 in other compensation.

Rankings

In 2013, Caesar J. Belbel's compensation ranked 7,047th out of 12,286 executives tracked by ExecPay. In other words, Belbel earned more than 42.6% of executives.

ClassificationRankingPercentile
All
7,047
out of 12,286
43rd
Division
Manufacturing
2,510
out of 4,612
46th
Major group
Chemicals And Allied Products
768
out of 1,462
48th
Industry group
Drugs
569
out of 1,156
51st
Industry
Pharmaceutical Preparations
456
out of 890
49th
Source: SEC filing on April 30, 2014.

Belbel's colleagues

We found four more compensation records of executives who worked with Caesar J. Belbel at ZIOPHARM Oncology in 2013.

2013

Jonathan Lewis

ZIOPHARM Oncology

Chief Executive Officer

2013

Hagop Youssoufian

ZIOPHARM Oncology

Chief Medical Officer

2013

Jason Amello

ZIOPHARM Oncology

Chief Financial Officer

2013

Kevin Lafond

ZIOPHARM Oncology

Chief Accounting Officer

In-depth

You may also like